BASF Shares Reach Annual Peak as Short Sellers Flee and Analysts Clash

BASF shares surge as short interest plummets 63%. Rally fueled by buybacks, a dividend, and government logistics investment, despite analyst debate on debt and outlook.

Shares in German chemical giant BASF have surged to a fresh 52-week high, trading at €54.70, a move accompanied by a dramatic exodus of bearish investors. Data from MarketBeat reveals short interest in the company's US-traded ADRs has collapsed by over 63% to just around 52,000 shares, leaving minimal theoretical resistance with a "Days-to-Cover" ratio of a mere 0.1 days. This capitulation underscores a significant shift in market sentiment toward the Ludwigshafen-based firm.

The stock's powerful rally, which has seen it gain 22% since the start of the year, is being underpinned by concrete corporate actions. BASF has reinforced its commitment to shareholder returns by formally continuing its ongoing share buyback program and confirming a planned dividend of €2.25 per share for the fiscal year. Market observers interpret this capital return strategy as a deliberate effort to secure shareholder value amidst a challenging macroeconomic climate.

Operational developments are providing additional support. The German federal government has pledged approximately €51 million to upgrade the combined transport terminal at BASF's Ludwigshafen headquarters. This investment, aimed at replacing outdated facilities by 2028, is designed to significantly boost logistics efficiency. Concurrently, the company is advancing its decarbonization agenda with the recent delivery of a 95-tonne component for an industrial-scale heat pump. This unit is slated to enable CO2-free steam generation from mid-2027, future-proofing its core production site.

Despite these tailwinds, a deep schism exists among major investment banks regarding BASF's outlook. Goldman Sachs maintains a bullish €63 price target, while Barclays adopts a far more cautious stance with a €40 valuation, citing the company's substantial debt burden. J.P. Morgan also aligns with the skeptical camp. The debate hinges on several key factors: the firm's pricing power, evidenced by announced price hikes of up to 30% in its Care Chemicals division; an accelerated cost-saving program targeting annual savings of €2.3 billion by the end of 2026; and persistent headwinds from weak industrial demand in Europe pressuring core business margins.

Management's own guidance adds to the cautious narrative, targeting an adjusted EBITDA between €6.2 and €7.0 billion for 2026—a range whose upper end slightly trails initial market expectations. This conservative planning accounts for uncertainties in US trade policy and a calculated Brent crude oil price of $65 per barrel. The company's net debt currently sits at 2.7 times EBITDA, a key metric watched by concerned analysts.

All eyes are now set for a definitive test on April 30. On that day, BASF will hold its Annual General Meeting for a shareholder vote on the dividend and, more critically, will release its first-quarter results. These figures will prove whether the recent explosive share price performance is supported by genuine volume growth in the underlying business or if the high debt load will ultimately stall the upward trend.